Mytesi
Resources

ResourcesDigital2023-08-24T19:38:21+00:00

Group 3307zzz

mo-Group 3307zzz

NapoCares^TM support program can help patients start and stay on their Mytesi treatment^*

• Support for prior authorizations and appeals^†

• Patient call center to answer questions

• Copay Savings Program to help with out-of-pocket costs^‡

• Benefits investigations and reimbursement support

• Patient assistance programs for uninsured patients

• Specialty pharmacy triage and coordination

Mytesi Copay Savings Program

Eligible patients may enroll in the savings program and download their Mobile Savings Card at napocares.com. Most eligible patients will pay as little as $0 for their Mytesi prescriptions.^*

You may also enroll your eligible^‡ patients in the Copay Savings Program by calling NapoCares^TM at (888) 527-NAPO (6276), M-F, 8am-8pm EST.

^*Subject to eligibility. Restrictions apply. Rx only.
^†Not a coverage guarantee.
^‡Patient must be commercially insured for eligibility. Subject to change or
cancellation at any time and without notice.

NapoCares^TM Patient Assistance Program (PAP)

Mytesi may be available to patients at no cost through NapoCares^TM
Patient Assistance Program (PAP). Eligible patients include those:

Mask Group 67

Mask Group 68

Mask Group 69

NapoCares^TM offers help for your Mytesi patients

Download NapoCares^TM Patient

Support Program enrollment form

Download guidance for Letter

of Medical Necessity

Download NapoCares^TM

PAP application form

Mask Group 73

LEARN MORE ABOUT
NAPOCARES^TM

OR CALL
(888) 527-NAPO (6276)

Mytesi is exclusively available through select
specialty pharmacies

Not sure which specialty pharmacy to use?

NapoCares™ can help you and your patients determine the right one.

Find a Mytesi specialty pharmacy

Napo Pharmaceuticals has resources to help you and your patients

Patient Education Resources

Patient start card

Patient access handout

HCP Education Resources

Group 2766

Diarrhea discussion guide

SPECIALTY PHARMACY pamphlet

resource-circle-leaf@2x

For product information and inquiries or to report an adverse event, please contact the Mytesi Call Center at (844) 722-8256 or by email at product.inquiries@napopharma.com

© 2023 Napo Pharmaceuticals Inc. MYT-P-0099

Read Important Safety Information about Mytesi

Read Important Safety Information about Mytesi

VIEW MORE +

VIEW MORE +

VIEW LESS −

VIEW LESS −

Mytesi (crofelemer) is an antidiarrheal drug indicated for symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS who are on antiretroviral therapy (ART)

Mytesi (crofelemer) is an antidiarrheal drug indicated for symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS who are on antiretroviral therapy (ART)

Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).

Please See Full Prescribing Information

Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).

Please See Full Prescribing Information

12107_Bud_Update_Mini@2x

To get more information
about Mytesi, sign up below.

Simple Email Subscriber Form